The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...

TOKYO--(BUSINESS WIRE)--Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), and SPERA PHARMA, Inc.

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for convenience and requiring advanced formulation techniques. Rapid scaling of ...

Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.

The biggest untapped resource in the health sector is not a new drug or AI-driven breakthrough—it's the patient’s voice. For decades, the pharmaceutical industry has revolved around science, ...

DeFloria Advancing Charlotte's Web Legacy as Pioneer in Cannabinoid Health, with Phase 2 Clinical Trials for Autism Botanical Drug Born from the founders of Charlotte's Web - the market leading brand ...

Bioprocessing is an umbrella term that describes the research, development, manufacturing, and commercialization of products derived from or used by biological systems. For industrial purposes, ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

Capital allocation depends heavily on perceived stability. Brand Finance analysis of US companies shows stronger brand ...